TIAA CREF Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $46.2M | Buy |
|
|||||
|
2018
Q4 | $16.5M | Sell |
|
|||||
|
2018
Q3 | $40.2M | Buy |
|
|||||
|
2018
Q2 | $31.7M | Buy |
|
|||||
|
2018
Q1 | $25.5M | Sell |
|
|||||
|
2017
Q4 | $27.3M | Buy |
|
|||||
|
2017
Q3 | $18.8M | Sell |
|
|||||
|
2017
Q2 | $15.1M | Buy |
|
|||||
|
2017
Q1 | $11.8M | Buy |
|
|||||
|
2016
Q4 | $8.98M | Buy |
|
|||||
|
2016
Q3 | $9.21K | Buy |
|
|||||
|
2016
Q2 | $7.87M | Sell |
|
|||||
|
2016
Q1 | $13.9M | Buy |
|
|||||
|
2015
Q4 | $18.5M | Buy |
|
|||||
|
2015
Q3 | $12.1M | Buy |
|
|||||
|
2015
Q2 | $13.9M | Buy |
|
|||||
|
2015
Q1 | $11.4M | Buy |
|
|||||
|
2014
Q4 | $6M | Sell |
|
|||||
|
2014
Q3 | $4.72M | Sell |
|
|||||
|
2014
Q2 | $4.58M | Buy |
|
|||||
|
2014
Q1 | $4.73M | Buy |
|
|||||
|
2013
Q4 | $2.68M | Hold |
|
|||||
|
2013
Q3 | $3.24M | Sell |
|
|||||
|
2013
Q2 | $3.93M | Buy |
|